Back

Relationship between NT-proBNP levels and BMI on clinical outcomes in heart failure: attenuation of the obesity paradox at higher disease severity

12 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Comorbidities and multimorbidity (2) Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Martin Moses Yu

National University Heart Center Singapore, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail
Baseline demographic and comorbidity burden of patients with supranormal glomerular filtration rate: a distinct phenotype?
Associate Professor S. Unlu (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Income and education as determinants of hospital utilization but not mortality in heart failure
Miss A. Carrete (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Longitudinal trajectories in clinical status and cardiac remodeling across the heart failure spectrum: 12-month evidence from the BRING-UP-3 HF Study
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Low-activity alerts as a prognostic marker in ICD/CRT
Doctor I. Almeida (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
TAPSE/sPAP ratio predicts 1-Year mortality in cardiac resynchronization therapy recipients with heart failure background
Doctor F. Oguz (Ankara, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and multimorbidity (2)

The Event

Event poster

Heart Failure 2026

12 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
The obesity paradox in heart failure: insights from a nationwide multi-ethnic Asian cohort
thumbnail
Congress Presentation
Patients hospitalised due to acute heart failure: baseline characteristics, clinical presentation, echocardiographic data and outcomes among the body mass index categories
thumbnail
Congress Presentation
The ambiguity of the paradox of obesity in patients with heart failure with reduced versus preserved ejection fraction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources